# Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

> **NCT00513461** · PHASE2 · COMPLETED · sponsor: **Chao Family Comprehensive Cancer Center** · enrollment: 110 (actual)

## Conditions studied

- Adult Primary Liver Cancer
- Hepatitis C Infection

## Interventions

- **DRUG:** S-adenosyl-L-methionine disulfate p-toluene-sulfonate
- **OTHER:** placebo
- **OTHER:** laboratory biomarker analysis
- **OTHER:** immunoenzyme technique
- **OTHER:** high performance liquid chromatography

## Key facts

- **NCT ID:** NCT00513461
- **Lead sponsor:** Chao Family Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2012-08
- **Final completion:** 2013-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00513461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00513461, "Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00513461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*